Tracking and predicting COVID-19 radiological trajectory on chest X-rays using deep learning.

Journal: Scientific reports
Published Date:

Abstract

Radiological findings on chest X-ray (CXR) have shown to be essential for the proper management of COVID-19 patients as the maximum severity over the course of the disease is closely linked to the outcome. As such, evaluation of future severity from current CXR would be highly desirable. We trained a repurposed deep learning algorithm on the CheXnet open dataset (224,316 chest X-ray images of 65,240 unique patients) to extract features that mapped to radiological labels. We collected CXRs of COVID-19-positive patients from an open-source dataset (COVID-19 image data collection) and from a multi-institutional local ICU dataset. The data was grouped into pairs of sequential CXRs and were categorized into three categories: 'Worse', 'Stable', or 'Improved' on the basis of radiological evolution ascertained from images and reports. Classical machine-learning algorithms were trained on the deep learning extracted features to perform immediate severity evaluation and prediction of future radiological trajectory. Receiver operating characteristic analyses and Mann-Whitney tests were performed. Deep learning predictions between "Worse" and "Improved" outcome categories and for severity stratification were significantly different for three radiological signs and one diagnostic ('Consolidation', 'Lung Lesion', 'Pleural effusion' and 'Pneumonia'; all P < 0.05). Features from the first CXR of each pair could correctly predict the outcome category between 'Worse' and 'Improved' cases with a 0.81 (0.74-0.83 95% CI) AUC in the open-access dataset and with a 0.66 (0.67-0.64 95% CI) AUC in the ICU dataset. Features extracted from the CXR could predict disease severity with a 52.3% accuracy in a 4-way classification. Severity evaluation trained on the COVID-19 image data collection had good out-of-distribution generalization when testing on the local dataset, with 81.6% of intubated ICU patients being classified as critically ill, and the predicted severity was correlated with the clinical outcome with a 0.639 AUC. CXR deep learning features show promise for classifying disease severity and trajectory. Once validated in studies incorporating clinical data and with larger sample sizes, this information may be considered to inform triage decisions.

Authors

  • Daniel Gourdeau
    CERVO Brain Research Center, Québec, Québec, Canada. daniel.gourdeau.1@ulaval.ca.
  • Olivier Potvin
    Centre de recherche CERVO, 2601 de la Canardière, Québec, G1J 2G3, Canada.
  • Patrick Archambault
    Department of Family and Emergency Medicine, Université Laval; Québec, QC, Canada; Research Chair in Emergency Medicine Laval University-CHAU Hôtel-Dieu de Lévis Hospital; Lévis City, QC, Canada.
  • Carl Chartrand-Lefebvre
    Centre hospitalier de l'Université de Montréal, Montréal, Canada.
  • Louis Dieumegarde
    Centre de recherche CERVO, 2601 de la Canardière, Québec, G1J 2G3, Canada.
  • Reza Forghani
    Department of Radiology, McGill University Health Centre, 1001 Decarie Blvd, Room C02.5821, Montreal, QC, Canada H4A 3J1; Augmented Intelligence & Precision Health Laboratory (AIPHL), Research Institute of the McGill University Health Centre, Montreal, Canada; Segal Cancer Centre and Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, Canada; and Department of Otolaryngology-Head and Neck Surgery, McGill University, Montreal, Canada.
  • Christian Gagne
  • Alexandre Hains
    Electrical and Computer Engineering Department, Université Laval, Québec, Canada.
  • David Hornstein
    Université McGill, Quebec, Canada.
  • Huy Le
    Department of Bioengineering, University of California, San Diego, CA, United States of America.
  • Simon Lemieux
    Department of Radiology and Nuclear Medicine, Université Laval, Québec, Québec, Canada.
  • Marie-Hélène Lévesque
    Department of Radiology and Nuclear Medicine, Université Laval, Québec, Québec, Canada.
  • Diego Martín
    Technical University of Madrid, Av. Complutense 30, 28040, Madrid, Spain, diego.martin.de.andres@upm.es.
  • Lorne Rosenbloom
    Jewish General Hospital, Montréal, Canada.
  • An Tang
    Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Canada.
  • Fabrizio Vecchio
    Department of Neuroscience and Neurorehabilitation, IRCCS San Raffaele, Rome, Italy.
  • Issac Yang
    Jewish General Hospital, Montréal, Canada.
  • Nathalie Duchesne
    Department of Radiology and Nuclear Medicine, Université Laval, Québec, Québec, Canada.
  • Simon Duchesne